TL;DR
This study investigates the genetic link between osteoporosis (OP) and schizophrenia (SCZ), finding significant genetic correlations that suggest a shared biological basis. By employing a trans-ethnic, two-stage approach, the researchers identified novel candidate genes and pathways, offering crucial insights into the increased risk of OP in SCZ patients.
What Problem Does This Paper Address?
Osteoporosis (OP) and schizophrenia (SCZ) are distinct conditions, yet clinical observations suggest a higher prevalence of OP in individuals with SCZ. While previous hypotheses have pointed to environmental factors like antipsychotic treatment, lifestyle, and diet, the underlying biological mechanisms, particularly the genetic underpinnings of this association, remain largely unexplored. This paper aims to bridge this knowledge gap by systematically investigating the genetic correlation between these two complex traits.
Methods
The study employed a two-stage trans-ethnic approach:
- Stage 1: Polygenic Risk Scoring (PRS) Analysis: This involved calculating polygenic risk scores for SCZ in Caucasian discovery samples and then using these scores to predict OP status. The same was done for Chinese replication samples. PRS analysis is a standard method for estimating an individual's genetic predisposition to a trait based on genome-wide association study (GWAS) data.
- Stage 2: Multi-trait Analysis of GWAS (MTAG): This advanced technique was used to jointly analyze GWAS summary datasets of OP and SCZ. MTAG is designed to increase statistical power for detecting novel causal loci by integrating information from related traits, thereby identifying genes that might influence both conditions.
- LD Score Regression: This method was used to evaluate the genetic correlation between OP and SCZ, providing a genome-wide measure of shared genetic architecture. It's a robust approach for disentangling confounding factors like population stratification.
- Functional Gene Set Enrichment Analysis (FUMA): Candidate genes identified through MTAG were further analyzed using FUMA to understand their involvement in biological pathways and tissue specificity.
Datasets
The study utilized existing GWAS summary datasets and collected new samples for replication:
- Caucasian Discovery Samples: 2286 Caucasian subjects for osteoporosis (OP).
- Chinese Replication Samples: 4124 Chinese subjects (1627 for OP, 1475 SCZ patients, and 1022 healthy controls).
- GWAS Summary Dataset 1 of SCZ (GWASSCZ1): A large-scale meta-analysis of SCZ comprising 34,241 cases and 45,604 controls from European and East Asian ancestries.
Key Insights and Ideas
- Shared Genetic Architecture: The most significant finding is the robust evidence for a shared genetic basis between OP and SCZ, particularly concerning bone phenotypes like ulna & radius area and BMD. This challenges the notion that the increased OP risk in SCZ is solely due to environmental factors.
- Trans-ethnic Validation: The study's strength lies in its trans-ethnic design, where initial findings in Caucasian populations were replicated in Chinese populations, increasing the generalizability of the results.
- Novel Candidate Genes: MTAG analysis successfully identified novel candidate genes, such as CTNNA2 for SCZ and FADS2 for OP, which were previously not strongly linked to both conditions.
- Pathway Involvement: Gene set enrichment analysis pointed towards specific biological pathways, including neuroactive ligand-receptor interaction and calcium signaling, as potentially mediating the genetic link between OP and SCZ.
Key Results
- Significant Genetic Correlations:
- In Caucasian discovery samples: Ulna & radius BMD vs. SCZ (P=0.010), Ulna & radius area vs. SCZ (P=0.031).
- In Chinese replication samples: Ulna & radius area vs. SCZ (P=0.019).
- LD Score regression also identified significant correlations, including hip total BMD vs. SCZ (P=0.0272) in Caucasians and ulna & radius BMD (P=0.0042) and whole body BMD (P=0.0027) vs. SCZ in Chinese samples.
- Novel Candidate Genes Identified by MTAG:
- CTNNA2 (MTAG P value = 2.24 × 10⁻⁶) for SCZ.
- FADS2 (MTAG P value = 2.66 × 10⁻⁷) for osteoporosis.
Limitations and Future Work
- Sample Size for MTAG: The Chinese replication sample sizes for OP and SCZ were relatively small, which might limit the interpretation of MTAG findings.
- Skeletal Site Specificity: The observed genetic correlations were primarily limited to specific skeletal sites (ulna & radius, and hip), suggesting that genetic factors might have site-specific effects on bone development.
- Mechanism Validation: The identified target molecules and pathways require validation through mechanism-based studies, including cell-based and animal experiments, to confirm their role in the development of both SCZ and OP.
The authors suggest that future research should focus on validating these findings and further elucidating the biological mechanisms underlying the identified genetic correlations.
Summary updated